Ambrose Kristen

SVP & Chief Accounting OfficerVERTEX PHARMACEUTICALS INC / MA (VRTX) · full profile →Form 4 · filed Feb 19, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.1M
Net Open-Market Flow
-$1.1M
Transactions
4
4 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 18, 2026Sell(S)638$473.68$302K8K
Feb 17, 2026Grant(A)2K$011K
Feb 17, 2026Tax withholding(F)598$483.75$289K10K
Feb 17, 2026Sell(S)2K$489.46$762K8K

Transaction Codes

S
Open-market sale
A
Grant / award
F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000875320-26-000080) within minutes of acceptance. Every field above traces to the original document. Verify it directly: